Clinical Operations, • 9/19/25 Optimizing CRO and Vendor Selection - Examples from the Field Previous Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Next Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Solutions for Trial Design Challenges in Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Aligning Trials with Patient-Lived Experiences Optimizing Rare Disease Clinical Trials with Real World Data Using NLP & AI What Matters to Payers: Conversations You Should Start During Phase 2
Clinical Operations, • 9/19/25 Optimizing CRO and Vendor Selection - Examples from the Field Previous Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Next Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Solutions for Trial Design Challenges in Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Aligning Trials with Patient-Lived Experiences Optimizing Rare Disease Clinical Trials with Real World Data Using NLP & AI What Matters to Payers: Conversations You Should Start During Phase 2
